Labcorp Holdings Inc. (LON:0JSY)

London flag London · Delayed Price · Currency is GBP · Price in USD
246.18
-2.17 (-0.87%)
At close: Jun 2, 2025
27.93%
Market Cap 15.31B
Revenue (ttm) 10.20B
Net Income (ttm) 565.63M
Shares Out n/a
EPS (ttm) 6.71
PE Ratio 27.07
Forward PE 15.40
Dividend 2.23 (0.90%)
Ex-Dividend Date May 29, 2025
Volume 121
Average Volume 165
Open 248.11
Previous Close 248.35
Day's Range 244.48 - 248.11
52-Week Range 192.43 - 258.58
Beta 0.81
RSI 53.29
Earnings Date Jul 31, 2025

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1995
Employees 70,000
Stock Exchange London Stock Exchange
Ticker Symbol 0JSY
Full Company Profile

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD Financial Statements

News

Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight

New York, USA, May 14, 2025 (GLOBE NEWSWIRE) -- Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight The expansion of the preeclampsia diagnostics market is...

19 days ago - Benzinga

Labcorp to Webcast Its Annual Meeting of Shareholders May 15

BURLINGTON, N.C., May 8, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be w...

25 days ago - PRNewsWire

Labcorp beats quarterly profit estimate on diagnostic test demand

Laboratory operator Labcorp beat analysts' estimate for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests.

5 weeks ago - Reuters

Labcorp Announces 2025 First Quarter Results

Updates Full-Year Guidance Results from Operations for first quarter 2025 versus first quarter last year: Revenue: $3.35 billion versus $3.18 billion Diluted EPS: $2.52 versus $2.69 Adjusted EPS: $3.8...

5 weeks ago - PRNewsWire

Earnings Scheduled For April 29, 2025

Companies Reporting Before The Bell • First Commonwealth (NYSE: FCF) is estimated to report quarterly earnings at $0.32 per share on revenue of $117.60 million. • CommVault Systems (NASDAQ: CVLT) is...

5 weeks ago - Benzinga

Earnings Preview: Laboratory Corp

Laboratory Corp (NYSE: LH) is set to give its latest quarterly earnings report on Tuesday, 2025-04-29. Here's what investors need to know before the announcement. Analysts estimate that Laboratory Co...

5 weeks ago - Benzinga

LifeMD Acquires Women's Health Provider Optimal Human Health MD to Accelerate Entry into the Women's Health Market

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading provider of virtual primary care services, today announced the acquisition of key assets from Optimal Human Health ...

5 weeks ago - Benzinga

Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions

Labcorp® Plasma Detect™ now available for clinical use to assess risk of recurrence in stage III colon cancer patients FDA-authorized liquid biopsy assay PGDx elio® plasma focus™ Dx now available to s...

5 weeks ago - PRNewsWire

Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics

Dublin, April 11, 2025 (GLOBE NEWSWIRE) -- The "Genetic Screening Testing for Preventive Health Market - A Global and Regional Analysis: Focus on Test Type, Technology, Application, End User and Count...

7 weeks ago - GlobeNewsWire

Labcorp Declares Quarterly Dividend

BURLINGTON, N.C. , April 10, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has...

7 weeks ago - PRNewsWire

Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease

Labcorp's pTau-217/Beta Amyloid 42 Ratio blood test meets the performance criteria to confirm amyloid pathology consistent with Alzheimer's disease BURLINGTON, N.C. , April 2, 2025 /PRNewswire/ -- Lab...

2 months ago - PRNewsWire

Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide

New offering expands screening options for cervical cancer and sexually transmitted infections (STIs), including chlamydia, gonorrhea, trichomonas or mycoplasma genitalium (Mgen) BURLINGTON, N.C. , Ap...

2 months ago - PRNewsWire

Labcorp to Announce First Quarter Financial Results on April 29, 2025

BURLINGTON, N.C. , March 31, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the firs...

2 months ago - PRNewsWire

Labcorp to buy certain assets of OPKO unit BioReference Health

Labcorp (NYSE:LH) stock gains after deal to acquire OPKO Health (OPK) unit BioReference Health's cancer-focused units for up to $225M. Read more here.

3 months ago - Seeking Alpha

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Transaction to extend Labcorp's leadership in oncology and expand access to the company's high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI , March 11, 2025 /PRNewswire/ -- Labcorp ...

3 months ago - PRNewsWire

Is the Market Bullish or Bearish on Labcorp Hldgs?

Labcorp Hldgs's (NYSE: LH) short percent of float has fallen 3.63% since its last report. The company recently reported that it has 1.83 million shares sold short , which is 2.92% of all regular shar...

3 months ago - Benzinga

Insider Sell: van der Vaart Sandra D Sells 1,314 Shares of Labcorp Holdings Inc (LH)

Insider Sell: van der Vaart Sandra D Sells 1,314 Shares of Labcorp Holdings Inc (LH)

3 months ago - GuruFocus

Insider Sell: Amy Summy Sells Shares of Labcorp Holdings Inc (LH)

Insider Sell: Amy Summy Sells Shares of Labcorp Holdings Inc (LH)

3 months ago - GuruFocus

Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight

Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight

3 months ago - GuruFocus

Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors

Labcorp® Plasma CompleteTM offers oncologists a highly sensitive and specific genomic profiling solution from a simple blood draw BURLINGTON, N.C. , Feb. 24, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a...

3 months ago - PRNewsWire

Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold'

Labcorp Holdings Inc., a leader in life sciences and diagnostics, is efficiently managing its financials and focusing on core strengths for long-term growth, warranting a “Hold” rating. Competitive ad...

3 months ago - Seeking Alpha